PUBLISHER: Grand View Research | PRODUCT CODE: 1790470
PUBLISHER: Grand View Research | PRODUCT CODE: 1790470
Companion Animal Infectious Disease Diagnostics Market Summary
The global companion animal infectious disease diagnostics market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.42 billion by 2033, growing at a CAGR of 7.44% from 2025 to 2033. The market continues to grow steadily, fueled by increasing pet ownership, a rising incidence of infectious diseases, and ongoing technological advancements in diagnostic tools.
Millennials represent the largest segment of pet owners, with around 66% of U.S. households owning a pet. As of 2024, approximately 65.1 million U.S. households have a dog, while 46.5 million own a cat. Moreover, the growing prevalence of infectious diseases among pets is a key driver of the companion animal infectious disease diagnostics industry, as it heightens the demand for timely and precise detection to help prevent outbreaks, lower mortality rates, and protect public health. For example, as reported by Sploot in January 2025, avian influenza (bird flu), an infectious disease caused by various influenza virus strains, experienced a multi-state outbreak in late 2024 and early 2025. The H5N1 strain has impacted commercial and backyard flocks, wild birds, and has also been found to infect humans, cats, and dogs.
Similarly, Canine influenza virus (CIV), commonly known as canine flu, is currently undergoing an outbreak in the U.S., driven by its highly contagious nature. The two prevalent strains, H3N8 and H3N2, are both influenza A viruses that spread swiftly through respiratory droplets, direct contact, and contaminated surfaces such as bowls, collars, or kennels. This rapid transmission, especially in high-density areas like shelters, daycare centers, and boarding facilities, underscores the urgent need for early and accurate detection.
As a result, the outbreak is significantly fueling growth in the companion animal infectious disease diagnostics industry. Veterinarians and pet healthcare providers are increasingly adopting advanced diagnostic tools, such as PCR-based tests and rapid antigen detection kits, to quickly identify infected animals, implement isolation protocols, and curb the spread of the virus. The heightened awareness among pet owners about the risks of canine flu and the necessity of timely intervention is further boosting demand for diagnostic services, positioning disease detection as a critical component of disease control and overall pet health management.
Furthermore, a key factor amplifying this demand is the generational shift in pet ownership behavior. Millennials and Gen Z now make up the majority of pet parents and are more likely to treat their animals as family members, prioritizing preventive healthcare and wellness diagnostics. According to IDEXX's 2024 survey, 73% of Millennials and 71% of Gen Z pet owners agree to at least annual wellness diagnostics for their pets. These younger owners are also more likely to adopt younger animals with 48% of Gen Z and 37% of Millennials owning dogs under two years old-fostering a long-term approach to health monitoring that starts early in the pet's life and continues throughout its lifespan.
Global Companion Animal Infectious Disease Diagnostics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal infectious disease diagnostics market report based on animal type, product, technology, Infection type, end-use, and region.